REPLIGEN CORP Shareholders' Equity
REPLIGEN CORP (RGEN) had Shareholders' Equity of $2.11 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-29
- 2026-06-30: Stockholders' Equity Attributable to Parent $2.11B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $2.11B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.11B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.08B.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $2.11B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $2.11B 10-Q · filed 2026-07-29 | |
| 2025-12-31 | $2.11B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $2.08B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $2.06B 10-Q · filed 2026-07-29 | |
| 2025-03-31 | $1.99B 10-Q · filed 2026-07-29 | |
| 2024-12-31 | $1.97B 10-Q · filed 2026-07-29 | |
| 2024-09-30 | $2.02B 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $1.98B 10-Q · filed 2025-11-04 | $1.99B 10-Q · filed 2024-07-30 |
| 2024-03-31 | $1.97B 10-Q · filed 2025-08-07 | $1.97B 10-Q · filed 2024-05-01 |
| 2023-12-31 | $1.96B 10-K · filed 2026-02-26 | $1.97B 10-K · filed 2024-02-22 |
| 2023-09-30 | $1.97B 10-Q/A · filed 2024-11-18 | $1.99B 10-Q · filed 2023-10-31 |
| 2023-06-30 | $1.96B 10-Q/A · filed 2024-11-18 | $1.97B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.93B 10-Q/A · filed 2024-11-18 | $1.94B 10-Q · filed 2023-05-02 |
| 2022-12-31 | $1.91B 10-K · filed 2026-02-26 | |
| 2022-09-30 | $1.84B 10-Q/A · filed 2024-11-18 | |
| 2022-06-30 | $1.81B 10-Q/A · filed 2024-11-18 | |
| 2022-03-31 | $1.77B 10-Q/A · filed 2024-11-18 | |
| 2021-12-31 | $1.75B 10-K · filed 2025-03-14 | |
| 2021-09-30 | $1.72B 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $1.60B 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $1.56B 10-Q · filed 2022-08-02 | |
| 2020-12-31 | $1.53B 10-K/A · filed 2024-11-18 | |
| 2020-09-30 | $1.12B 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $1.10B 10-Q · filed 2021-10-28 | |
| 2020-03-31 | $1.07B 10-Q · filed 2021-07-27 | |
| 2019-12-31 | $1.06B 10-K · filed 2023-02-22 | |
| 2019-09-30 | $1.05B 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $878.97M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $625.02M 10-Q · filed 2020-07-30 | |
| 2018-12-31 | $615.57M 10-K · filed 2022-02-17 | |
| 2018-09-30 | $606.49M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $598.66M 10-Q · filed 2019-10-31 | |
| 2018-03-31 | $597.18M 10-Q · filed 2019-08-01 | |
| 2017-12-31 | $591.55M 10-K · filed 2021-02-24 | |
| 2017-09-30 | $576.87M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $190.94M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $176.79M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $168.76M 10-K · filed 2020-02-26 | |
| 2016-09-30 | $166.52M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $163.72M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $128.89M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $122.75M 10-K · filed 2019-03-01 | |
| 2015-09-30 | $121.45M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $118.22M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $111.93M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $111.73M 10-K · filed 2018-02-22 | $111.73M 10-K · filed 2015-03-17 |
| 2014-09-30 | $114.59M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $115.56M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $108.85M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $84.12M 10-K · filed 2017-02-23 | $103.89M 10-K · filed 2014-03-14 |
| 2013-09-30 | $100.16M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $92.45M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $87.41M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $84.12M 10-K · filed 2016-02-25 | $84.12M 10-K · filed 2013-03-15 |
| 2012-09-30 | $73.70M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $68.73M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $68.67M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $65.99M 10-K · filed 2015-03-17 | |
| 2011-09-30 | $67.83M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $67.31M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $67.09M 10-K · filed 2013-03-15 | |
| 2010-12-31 | $67.09M 10-K · filed 2014-03-14 | |
| 2010-03-31 | $66.12M 10-K · filed 2013-03-15 | |
| 2009-03-31 | $69.12M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |